Market Overview:
The global breath actuated inhalers market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of respiratory diseases, such as asthma and COPD, and the growing demand for technologically advanced inhalers. The global breath actuated inhalers market is segmented on the basis of type, application, and region. On the basis of type, it is divided into single dose and multi-dose inhalers. Single dose inhalers are further classified into pressurized metered dose inhaler (pMDI) and dry powder inhaler (DPI). Multi-dose inhaled are further classified into nebulizers and autoinhalers. On the basis of application, it is divided into asthma, COPD other respiratory diseases), which include bronchitis chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), pneumonia,, idiopathic pulmonary fibrosis IPF,, sarcoidosis,, lung cancer,, tuberculosis). Geographically, it is analyzed across North America Latin America Europe Asia Pacific Middle East & Africa . Breath actuated Inhaler Devices have been used therapeutically for over 50 years; however their use has increased significantly in recent times due to technological advancements that have made these devices more user friendly with better outcomes.
Product Definition:
Breath Actuated Inhalers are devices that deliver medication to the lungs through a metered dose inhaler. This type of inhaler is activated when the user takes a breath in, which causes a spray of medication to be released. This type of inhaler is important because it allows for more accurate doses than other types of inhalers, and it also helps to ensure that all the medication reaches the lungs.
Single Dose:
Single dose inhalers (SDIs) are a class of drug delivery devices used to deliver medication in one administration. They comprise a dose, which is released at a precise time and place by the inhalation device. The most common application of SDIs is for the treatment of asthma where multiple daily doses are not feasible or when quick acting drugs are required.
The global market for SDI's was valued at USD 2,867 million in 2016.
Multi-dose:
Multi-dose is a device used in breath actuated inhalers. It consists of an ampoule containing dose and a valve which can be attached to the inhaler. The multi-dose inhaler delivers dose by the compressed air from the propellant chamber and it works as an asthma relief medication.
The advantages of using multi-dose are that it reduces medicine dosage, improves patient compliance, increases treatment efficacy & satisfaction and reduces adverse effects related to drug consumption.
Application Insights:
Asthma held the largest share of the application segment in 2017. This is attributed to high usage rates of inhalers for asthma treatment and increasing prevalence of asthma. According to data published by Global Asthma Report, around 300 million people across the world suffer from asthma. Prevalence rate for this disease is highest in North America and Europe followed by Asia Pacific region.
According to a study conducted by CDC between 2010-2012, it was estimated that around 47% adults living with bronchitis or emphysema were taking some form of prescription medicine while 43% were using over-the-counter (OTC) medicines for their coughs and 38% had visited a healthcare professional about their coughs and/or wheezing during the past year in U.S., Canada as well as European countries including United Kingdom, Germany Ireland France Spain Italy Portugal etc.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position throughout the forecast period owing to increasing R&D investments and technological advancements in devices. Moreover, high awareness levels regarding chronic respiratory diseases and their treatment options are also contributing towards growth in this region.
Asia Pacific is anticipated to witness lucrative growth over the forecast period due to rising disposable income, improving healthcare infrastructure, growing target population base with increased demand for inhalers due to rising prevalence of COPD and asthma as well as other chronic respiratory diseases (CORD). Furthermore, economic development coupled with rapid industrialization has led to an increase in production of breath actuated inhalers across emerging countries such as China & India which will further boost regional market growth during the estimated time span.
The European market was valued at USD X million in 2017.
Growth Factors:
- Increasing prevalence of respiratory diseases: The global prevalence of respiratory diseases is increasing every year. This is leading to an increase in the demand for breath actuated inhalers as they are the most effective way to treat these diseases.
- Technological advancements: The technology used in breath actuated inhalers is constantly evolving, making them more efficient and easier to use. This is resulting in an increase in their popularity among patients and healthcare professionals alike.
- Growing awareness about the benefits of breath actuated inhalers: There is a growing awareness about the benefits of using breath actuated inhalers, such as improved patient compliance and better treatment outcomes. This is helping to drive demand for these devices worldwide.
Scope Of The Report
Report Attributes
Report Details
Report Title
Breath Actuated Inhalers Market Research Report
By Type
Single Dose, Multi-dose
By Application
Asthma, COPD, Other
By Companies
GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Meda, Novartis, Schering/Merck
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Breath Actuated Inhalers Market Report Segments:
The global Breath Actuated Inhalers market is segmented on the basis of:
Types
Single Dose, Multi-dose
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Asthma, COPD, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- GlaxoSmithKline
- AstraZeneca
- Boehringer Ingelheim
- Chiesi
- Cipla
- 3M
- Hovione
- Mannkind
- Meda
- Novartis
- Schering/Merck
Highlights of The Breath Actuated Inhalers Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Single Dose
- Multi-dose
- By Application:
- Asthma
- COPD
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Breath Actuated Inhalers Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Breath Actuated Inhalers (BAI) are a type of medical device that helps people with breathing problems to breathe more easily. They work by using air pressure to help the person inhale and exhale.
Some of the major players in the breath actuated inhalers market are GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Chiesi, Cipla, 3M, Hovione, Mannkind, Meda, Novartis, Schering/Merck.
The breath actuated inhalers market is expected to register a CAGR of 5.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Breath Actuated Inhalers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Breath Actuated Inhalers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Breath Actuated Inhalers Market - Supply Chain
4.5. Global Breath Actuated Inhalers Market Forecast
4.5.1. Breath Actuated Inhalers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Breath Actuated Inhalers Market Size (000 Units) and Y-o-Y Growth
4.5.3. Breath Actuated Inhalers Market Absolute $ Opportunity
5. Global Breath Actuated Inhalers Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Breath Actuated Inhalers Market Size and Volume Forecast by Type
5.3.1. Single Dose
5.3.2. Multi-dose
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Breath Actuated Inhalers Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Breath Actuated Inhalers Market Size and Volume Forecast by Application
6.3.1. Asthma
6.3.2. COPD
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Breath Actuated Inhalers Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Breath Actuated Inhalers Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Breath Actuated Inhalers Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Breath Actuated Inhalers Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Breath Actuated Inhalers Demand Share Forecast, 2019-2029
9. North America Breath Actuated Inhalers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Breath Actuated Inhalers Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Breath Actuated Inhalers Market Size and Volume Forecast by Application
9.4.1. Asthma
9.4.2. COPD
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Breath Actuated Inhalers Market Size and Volume Forecast by Type
9.7.1. Single Dose
9.7.2. Multi-dose
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Breath Actuated Inhalers Demand Share Forecast, 2019-2029
10. Latin America Breath Actuated Inhalers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Breath Actuated Inhalers Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Breath Actuated Inhalers Market Size and Volume Forecast by Application
10.4.1. Asthma
10.4.2. COPD
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Breath Actuated Inhalers Market Size and Volume Forecast by Type
10.7.1. Single Dose
10.7.2. Multi-dose
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Breath Actuated Inhalers Demand Share Forecast, 2019-2029
11. Europe Breath Actuated Inhalers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Breath Actuated Inhalers Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Breath Actuated Inhalers Market Size and Volume Forecast by Application
11.4.1. Asthma
11.4.2. COPD
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Breath Actuated Inhalers Market Size and Volume Forecast by Type
11.7.1. Single Dose
11.7.2. Multi-dose
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Breath Actuated Inhalers Demand Share, 2019-2029
12. Asia Pacific Breath Actuated Inhalers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Breath Actuated Inhalers Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Breath Actuated Inhalers Market Size and Volume Forecast by Application
12.4.1. Asthma
12.4.2. COPD
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Breath Actuated Inhalers Market Size and Volume Forecast by Type
12.7.1. Single Dose
12.7.2. Multi-dose
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Breath Actuated Inhalers Demand Share, 2019-2029
13. Middle East & Africa Breath Actuated Inhalers Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Breath Actuated Inhalers Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Breath Actuated Inhalers Market Size and Volume Forecast by Application
13.4.1. Asthma
13.4.2. COPD
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Breath Actuated Inhalers Market Size and Volume Forecast by Type
13.7.1. Single Dose
13.7.2. Multi-dose
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Breath Actuated Inhalers Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Breath Actuated Inhalers Market: Market Share Analysis
14.2. Breath Actuated Inhalers Distributors and Customers
14.3. Breath Actuated Inhalers Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. GlaxoSmithKline
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. AstraZeneca
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Boehringer Ingelheim
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Chiesi
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Cipla
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. 3M
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Hovione
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Mannkind
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Meda
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Novartis
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Schering/Merck
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
